You searched for "tarsal"
New prognostic model for multiple sclerosis after optic neuritis presentation
2 August 2022
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a post-hoc analysis using the publicly available data set from the Optic Neuritis Treatment Trial. The Cox proportional hazards regression models were used to assess for associations between clinical and radiological variables and the development of clinical...
Intravitreal bevacizumab vs. triamcinolone in patients with DMO at the time of cataract surgery
1 October 2016
| Anjali Gupta
|
EYE - Vitreo-Retinal
This prospective, single masked randomised control trial (RCT) compared visual and anatomical outcomes when either intravitreal bevacizumab (BVB) or triamcinolone (TA) was administered at the time of cataract surgery and at subsequent review, if required, in patients with diabetic macula...
Platelet-rich fibrin for conjunctivoplasty after pterygium excision
The authors report a prospective, comparative, non-randomized clinical trial of 35 pterygium patients with unilateral nasal primary pterygium infiltrating the cornea 2-5mm in size, who underwent pterygium excision between June 2013 and September 2014. Thirty-five eyes of 35 patients with...Steroid-eluting Spongostan improves endoscopic DCR success
This is a retrospective analysis of a change in technique for endoscopic dacryocystorhinostomy (endo-DCR) surgery. The authors compared the outcomes of 55 patients between 2011 and 2013 with 187 from 2013 to 2020 who all underwent endo-DCR. In 2013 the...Herpes zoster ophthalmicus: the essentials
Herpes zoster, also referred to as shingles, is a common infection most typically caused by the reactivation of varicella zoster virus that lies dormant (sometime for decades) in the dorsal root nerve ganglion following primary chickenpox infection [1]. In 10-20%...Presumed DALK stromal graft rejection following Covid-19 infection
4 December 2024
| Mary-Therese Monaghan, Shokufeh Tavassoli
|
EYE - Cornea
Case report A 45-year-old healthy male patient with a past ocular history of keratoconus and right deep-anterior lamellar keratoplasty (DALK) graft performed 10 months prior, presented to our eye casualty clinic with a two-day history of right photophobia and epiphora....
Diagnoses of dry eye disease double within a year
27 September 2022
Over a third of Britons haven’t had an eye test within the last two years, while one in five have not had an eye test due to financial struggles.
A missed intraocular telescope – an opportunity to re-focus the evidence
4 February 2021
| Hani Hasan, Jennifer McMahon, Guy Smith
|
EYE - Cornea, EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
Intraocular telescopes allow magnification of the image so that it would be projected into a larger area of the macula, this makes the central defect caused by dry age-related macular degeneration (AMD) smaller. The most common approach is a Galilean...
Effective management of dry eye and ocular surface disease
4 August 2021
| Rod McNeil
|
EYE - General
Experts recommend a consistent approach to diagnosis, therapeutic targeting by disease subtype and escalation of therapy when tear substitutes are not sufficient. Experts call for a consistent, unified approach to diagnosis of dry eye disease (DED), with a new simple...
Choroidal and RNFL thickness in patients with OSAS
1 August 2015
| Anjali Gupta
|
EYE - Vitreo-Retinal
In obstructive sleep apnoea syndrome (OSAS), hypoxia secondary to repetitive apnoeic episodes leads to blood pressure variations and haemodynamic changes. There is also intermittent activation of the sympathetic system when the patient is aroused from sleep during apnoeic episodes. OSAS...
Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service
4 August 2021
| Jane Ashworth, Tsveta Ivanova, Susmito Biswas, Assad Jalil, Georgina Hall, Rebecca Redmond, Graeme CM Black (Prof), William Newman, Neil Parry, Jane CB Gray, Charlotte Skitterall
|
EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...